192 related articles for article (PubMed ID: 29113987)
21. BAP1 suppresses lung cancer progression and is inhibited by miR-31.
Yu M; Liang H; Fu Z; Wang X; Liao Z; Zhou Y; Liu Y; Wang Y; Hong Y; Zhou X; Yan X; Yu M; Ma M; Zhang W; Guo B; Zhang J; Zen K; Zhang CY; Wang T; Zhang Q; Chen X
Oncotarget; 2016 Mar; 7(12):13742-53. PubMed ID: 26885612
[TBL] [Abstract][Full Text] [Related]
22. A 13-gene expression-based radioresistance score highlights the heterogeneity in the response to radiation therapy across HPV-negative HNSCC molecular subtypes.
Foy JP; Bazire L; Ortiz-Cuaran S; Deneuve S; Kielbassa J; Thomas E; Viari A; Puisieux A; Goudot P; Bertolus C; Foray N; Kirova Y; Verrelle P; Saintigny P
BMC Med; 2017 Sep; 15(1):165. PubMed ID: 28859688
[TBL] [Abstract][Full Text] [Related]
23. BAP1 links metabolic regulation of ferroptosis to tumour suppression.
Zhang Y; Shi J; Liu X; Feng L; Gong Z; Koppula P; Sirohi K; Li X; Wei Y; Lee H; Zhuang L; Chen G; Xiao ZD; Hung MC; Chen J; Huang P; Li W; Gan B
Nat Cell Biol; 2018 Oct; 20(10):1181-1192. PubMed ID: 30202049
[TBL] [Abstract][Full Text] [Related]
24. The BAP1/ASXL2 Histone H2A Deubiquitinase Complex Regulates Cell Proliferation and Is Disrupted in Cancer.
Daou S; Hammond-Martel I; Mashtalir N; Barbour H; Gagnon J; Iannantuono NV; Nkwe NS; Motorina A; Pak H; Yu H; Wurtele H; Milot E; Mallette FA; Carbone M; Affar el B
J Biol Chem; 2015 Nov; 290(48):28643-63. PubMed ID: 26416890
[TBL] [Abstract][Full Text] [Related]
25. Spleen tyrosine kinase expression is correlated with human papillomavirus in head and neck cancer.
Black M; Ghasemi F; Sun RX; Stecho W; Datti A; Meens J; Pinto N; Ruicci KM; Khan MI; Han MW; Shaikh M; Yoo J; Fung K; MacNeil D; Palma DA; Winquist E; Howlett CJ; Mymryk JS; Ailles L; Boutros PC; Barrett JW; Nichols AC
Oral Oncol; 2020 Feb; 101():104529. PubMed ID: 31864959
[TBL] [Abstract][Full Text] [Related]
26. Oct4 confers stemness and radioresistance to head and neck squamous cell carcinoma by regulating the homologous recombination factors PSMC3IP and RAD54L.
Nathansen J; Lukiyanchuk V; Hein L; Stolte MI; Borgmann K; Löck S; Kurth I; Baumann M; Krause M; Linge A; Dubrovska A
Oncogene; 2021 Jun; 40(24):4214-4228. PubMed ID: 34079088
[TBL] [Abstract][Full Text] [Related]
27. BAP1/ASXL1 recruitment and activation for H2A deubiquitination.
Sahtoe DD; van Dijk WJ; Ekkebus R; Ovaa H; Sixma TK
Nat Commun; 2016 Jan; 7():10292. PubMed ID: 26739236
[TBL] [Abstract][Full Text] [Related]
28. Growth inhibition and chemo-radiosensitization of head and neck squamous cell carcinoma (HNSCC) by survivin-siRNA lentivirus.
Khan Z; Khan AA; Prasad GB; Khan N; Tiwari RP; Bisen PS
Radiother Oncol; 2016 Feb; 118(2):359-68. PubMed ID: 26747757
[TBL] [Abstract][Full Text] [Related]
29. Demethylation Therapy as a Targeted Treatment for Human Papillomavirus-Associated Head and Neck Cancer.
Biktasova A; Hajek M; Sewell A; Gary C; Bellinger G; Deshpande HA; Bhatia A; Burtness B; Judson B; Mehra S; Yarbrough WG; Issaeva N
Clin Cancer Res; 2017 Dec; 23(23):7276-7287. PubMed ID: 28916527
[No Abstract] [Full Text] [Related]
30. Regulation of B Lymphocyte Development by Histone H2A Deubiquitinase BAP1.
Lin YH; Liang Y; Wang H; Tung LT; Förster M; Subramani PG; Di Noia JM; Clare S; Langlais D; Nijnik A
Front Immunol; 2021; 12():626418. PubMed ID: 33912157
[TBL] [Abstract][Full Text] [Related]
31. FGFR1 Is a Potential Prognostic Biomarker and Therapeutic Target in Head and Neck Squamous Cell Carcinoma.
Koole K; Brunen D; van Kempen PM; Noorlag R; de Bree R; Lieftink C; van Es RJ; Bernards R; Willems SM
Clin Cancer Res; 2016 Aug; 22(15):3884-93. PubMed ID: 26936917
[TBL] [Abstract][Full Text] [Related]
32. BAP1 promotes breast cancer cell proliferation and metastasis by deubiquitinating KLF5.
Qin J; Zhou Z; Chen W; Wang C; Zhang H; Ge G; Shao M; You D; Fan Z; Xia H; Liu R; Chen C
Nat Commun; 2015 Sep; 6():8471. PubMed ID: 26419610
[TBL] [Abstract][Full Text] [Related]
33. Tumor suppressor BAP1 is essential for thymic development and proliferative responses of T lymphocytes.
Arenzana TL; Lianoglou S; Seki A; Eidenschenk C; Cheung T; Seshasayee D; Hagenbeek T; Sambandam A; Noubade R; Peng I; Lesch J; DeVoss J; Wu X; Lee WP; Caplazi P; Webster J; Liu J; Pham VC; Arnott D; Lill JR; Modrusan Z; Dey A; Rutz S
Sci Immunol; 2018 Apr; 3(22):. PubMed ID: 29678836
[TBL] [Abstract][Full Text] [Related]
34. MiR-31-5p alleviates septic cardiomyopathy by targeting BAP1 to inhibit SLC7A11 deubiquitination and ferroptosis.
Liu Y; Hu N; Ai B; Xia H; Li W
BMC Cardiovasc Disord; 2024 May; 24(1):286. PubMed ID: 38816686
[TBL] [Abstract][Full Text] [Related]
35. The BAP1 nuclear deubiquitinase is involved in the nonhomologous end-joining pathway of double-strand DNA repair through interaction with DNA-PK.
Sato H; Ito T; Hayashi T; Kitano S; Erdjument-Bromage H; Bott MJ; Toyooka S; Zauderer M; Ladanyi M
Oncogene; 2024 Apr; 43(15):1087-1097. PubMed ID: 38383726
[TBL] [Abstract][Full Text] [Related]
36. SLC3A2/CD98hc, autophagy and tumor radioresistance: a link confirmed.
Digomann D; Linge A; Dubrovska A
Autophagy; 2019 Oct; 15(10):1850-1851. PubMed ID: 31276435
[TBL] [Abstract][Full Text] [Related]
37. Retracted: Histone H2B ubquitination regulates retinoic acid signaling through the cooperation of ASXL1 and BAP1.
Lee SW; Youn H; Kim EJ; Um SJ
Mol Cell; 2013 Jul; 51(2):200-10. PubMed ID: 23850490
[TBL] [Abstract][Full Text] [Related]
38. Rare germline heterozygous missense variants in BRCA1-associated protein 1, BAP1, cause a syndromic neurodevelopmental disorder.
Küry S; Ebstein F; Mollé A; Besnard T; Lee MK; Vignard V; Hery T; Nizon M; Mancini GMS; Giltay JC; Cogné B; McWalter K; Deb W; Mor-Shaked H; Li H; Schnur RE; Wentzensen IM; Denommé-Pichon AS; Fourgeux C; Verheijen FW; Faurie E; Schot R; Stevens CA; Smits DJ; Barr E; Sheffer R; Bernstein JA; Stimach CL; Kovitch E; Shashi V; Schoch K; Smith W; van Jaarsveld RH; Hurst ACE; Smith K; Baugh EH; Bohm SG; Vyhnálková E; Ryba L; Delnatte C; Neira J; Bonneau D; Toutain A; Rosenfeld JA; ; Audebert-Bellanger S; Gilbert-Dussardier B; Odent S; Laumonnier F; Berger SI; Smith ACM; Bourdeaut F; Stern MH; Redon R; Krüger E; Margueron R; Bézieau S; Poschmann J; Isidor B
Am J Hum Genet; 2022 Feb; 109(2):361-372. PubMed ID: 35051358
[TBL] [Abstract][Full Text] [Related]
39. Taselisib (GDC-0032), a Potent β-Sparing Small Molecule Inhibitor of PI3K, Radiosensitizes Head and Neck Squamous Carcinomas Containing Activating PIK3CA Alterations.
Zumsteg ZS; Morse N; Krigsfeld G; Gupta G; Higginson DS; Lee NY; Morris L; Ganly I; Shiao SL; Powell SN; Chung CH; Scaltriti M; Baselga J
Clin Cancer Res; 2016 Apr; 22(8):2009-19. PubMed ID: 26589432
[TBL] [Abstract][Full Text] [Related]
40. Radiation-Induced Dedifferentiation of Head and Neck Cancer Cells Into Cancer Stem Cells Depends on Human Papillomavirus Status.
Vlashi E; Chen AM; Boyrie S; Yu G; Nguyen A; Brower PA; Hess CB; Pajonk F
Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1198-206. PubMed ID: 27026319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
